Common use of PAYMENTS IN CONSIDERATION FOR LICENSE Clause in Contracts

PAYMENTS IN CONSIDERATION FOR LICENSE. 15.1 Except as amended below, all payments set forth in Article III of the License Agreement shall remain unchanged. 15.2 Section 3.2 (a) of the License Agreement shall be amended to read as follows: (a) there is an enforceable BENTLEY Patent at the time of sale: The First $**** Million of Annual Net Sales * ***% The Next $**** Million of Annual Net Sales * ***% The Next $**** Million of Annual Net Sales * ***% Net Sales over $**** Million of Annual Net Sales * ***%

Appears in 1 contract

Sources: License Agreement (CPEX Pharmaceuticals, Inc.)

PAYMENTS IN CONSIDERATION FOR LICENSE. 15.1 3.1 Except as amended below, all payments set forth in Article III of the License Agreement shall remain unchanged. 15.2 3.2 Section 3.2 (a) of the License Agreement shall be amended to read as follows: (a) there is an enforceable BENTLEY Patent at the time of sale: The First $**** 1-15 Million of Annual Net Sales * ***20 % The Next $**** 15+-50 Million of Annual Net Sales * ***18 % The Next $**** 50+-100 Million of Annual Net Sales * ***16 % Net Sales over the First $**** 100 Million of Annual Net Sales * ***14 %

Appears in 1 contract

Sources: License Agreement (Auxilium Pharmaceuticals Inc)

PAYMENTS IN CONSIDERATION FOR LICENSE. 15.1 3.1 Except as amended below, all payments set forth in Article III of the License Agreement shall remain unchanged. 15.2 3.2 Section 3.2 (a) of the License Agreement shall be amended to read as follows: (a) there is an enforceable BENTLEY Patent at the time of sale: The First $**** Million of Annual Net Sales * ***% The Next $**** Million of Annual Net Sales * ***% The Next $**** Million of Annual Net Sales * ***% Net Sales over $**** Million of Annual Net Sales * ***%

Appears in 1 contract

Sources: License Agreement (CPEX Pharmaceuticals, Inc.)

PAYMENTS IN CONSIDERATION FOR LICENSE. 15.1 Except as amended below, all payments set forth in Article III of the License Agreement shall remain unchanged. 15.2 Section 3.2 (a) of the License Agreement shall be amended to read as follows: (a) there is an enforceable BENTLEY Patent at the time of sale: The First $**** 1-15 Million of Annual Net Sales * ***20 % The Next $**** 15+-50 Million of Annual Net Sales * ***18 % The Next $**** 50+-100 Million of Annual Net Sales * ***16 % Net Sales over $**** 100 Million of Annual Net Sales * ***14 %

Appears in 1 contract

Sources: License Agreement (CPEX Pharmaceuticals, Inc.)

PAYMENTS IN CONSIDERATION FOR LICENSE. 15.1 3.1 Except as amended below, all payments set forth in Article III of the License Agreement shall remain unchanged. 15.2 3.2 Section 3.2 (a) of the License Agreement shall be amended to read as follows: (a) there is an enforceable BENTLEY Patent at the time of sale: The First $**** Million of Annual Net Sales * ***% The Next $**** Million of Annual Net Sales * ***% The Next $**** Million of Annual Net Sales * ***% Net Sales over $**** Million of Annual Net Sales * **over *%

Appears in 1 contract

Sources: License Agreement (Auxilium Pharmaceuticals Inc)